Rilzabrutinib authorised to treat adults with immune thrombocytopenia when prior treatments have been insufficient
seen at 14:55, 29 May in News and communications.Rilzabrutinib authorised to treat adults with immune thrombocytopenia when prior treatments have been insufficient
seen at 14:55, 29 May in News and communications.